Crossmark

Building a Case for Withaferin A as a Treatment for FTD/ALS Syndromes

Crossref DOI link: https://doi.org/10.1007/s13311-020-00991-7

Published Print: 2021-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Borchelt, David R. https://orcid.org/0000-0002-0813-6979
License Information

Text and Data Mining valid from 2021-01-01

Text and Data Mining valid from 2021-01-01

Version of Record valid from 2023-08-18
More Information

This article is maintained by: Elsevier

Article Title: Building a Case for Withaferin A as a Treatment for FTD/ALS Syndromes

Journal Title: Neurotherapeutics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-020-00991-7

Content Type: simple-article

Copyright: Copyright © 2021 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.